Company Filing History:
Years Active: 2015-2017
Title: Jeongun Hwang: Innovator in Pharmaceutical Composition
Introduction
Jeongun Hwang is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating metabolic diseases. With a total of 2 patents to his name, Hwang's work is paving the way for innovative treatments.
Latest Patents
Hwang's latest patents include a cyclohexene derivative and a pharmaceutical composition for preventing or treating metabolic diseases. The cyclohexene derivative enhances the intracellular activity of cyclic adenosine monophosphate (cAMP) by activating G protein-coupled receptor 119 (GPR-119). This compound exhibits weight loss and hypoglycemic effects by inducing the release of glucagon-like peptide-1 (GLP-1), making it a promising candidate for treating conditions such as obesity and diabetes. His second patent involves a compound for inhibiting human 11β-hydroxy steroid dehydrogenase type 1 (11β-HSD1), which shows excellent activity and solubility, enhancing its formulation and transfer efficiency.
Career Highlights
Jeongun Hwang is currently associated with Hyundai Pharm Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work focuses on developing effective treatments for metabolic disorders, showcasing his commitment to improving health outcomes.
Collaborations
Hwang collaborates with esteemed colleagues, including Jaekeol Rhee and Jin Wook Yang, to advance research and development in his field. Their combined expertise contributes to the success of their projects and the impact of their inventions.
Conclusion
Jeongun Hwang is a distinguished inventor whose work in pharmaceutical compositions is making strides in the treatment of metabolic diseases. His innovative patents reflect his dedication to enhancing healthcare solutions.